The DOI matches its Crossref record; 724 of the 724 references it cites were found in a registry or an index.
Purinergic Signalling: Therapeutic Developments
Open accessAbstract
Purinergic signalling, i.e. the role of nucleotides as extracellular signalling molecules, was proposed in 1972. However, this concept was not well accepted until the early 1990’s when receptor subtypes for purines and pyrimidines were cloned and characterised, which includes 4 subtypes of the P1 (adenosine) receptor, 7 subtypes of P2X ion channel receptors and 8 subtypes of the P2Y G protein-coupled receptor. Early studies were largely concerned with the physiology, pharmacology and biochemistry of purinergic signalling. More recently, the focus has been on the pathophysiology and therapeutic potential. There was early recognition of the use of P1 receptor agonists for the treatment of supraventicular tachycardia and A2A receptor antagonists are promising for the treatment of Parkinson’s disease. Clopidogrel, a P2Y¬12 antagonist, is widely used for the treatment of thrombosis and stroke, blocking P2Y¬12 receptor-mediated platelet aggregation. Diquafasol, a long acting P2Y¬2 receptor agonist, is being used for the treatment of dry eye. P2X3 receptor antagonists have been developed that are orally bioavailable and stable in vivo and are currently in clinical trials for the treatment of chronic cough, bladder incontinence, visceral pain and hypertension. Antagonists to P2X7 receptors are being investigated for the treatment of inflammatory disorders, including neurodegenerative diseases. Other investigations are in progress for the use of purinergic agents for the treatment of osteoporosis, myocardial infarction, irritable bowel syndrome, epilepsy, atherosclerosis, depression, autism, diabetes and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 724
Sun, X., Han, L., Seth, P., Shu, B., Li, L., Csizmadia, E., JUNGER, W. G., Schmelzle, M., Usheva, A., Tapper, E. B., et al. (2012) · Hepatology · doi:10.1002/hep.25989 · Cited by 90
Mattei, M. D., Varani, K., Masieri, F. F., Pellati, A., Ongaro, A., Fini, M., Cadossi, R., Vincenzi, F., Borea, P. A., & Caruso, A. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.06.002 · Cited by 90
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Hansen, R. R., Nielsen, C. K., Nasser, A., Thomsen, S. I. M., Eghorn, L. F., Pham, Y., Schulenburg, C., Syberg, S., Ding, M. L., Stojilković, S. S., et al. (2011) · Pain · doi:10.1016/j.pain.2011.03.024 · Cited by 90
P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice
Zhang, K., Liu, J., You, X., Kong, P., Song, Y., Cao, L., Yang, S. T., Wang, W., Fu, Q., & Ma, Z. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.043 · Cited by 90
The P2X7receptor as a therapeutic target
Romagnoli, R., Baraldi, P. G., Cruz‐López, O., Lopez-Cara, L. C., Preti, D., Borea, P. A., & Gessi, S. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.647 · Cited by 89
Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury
Hoegl, S., Brodsky, K. S., Blackburn, M. R., Karmouty‐Quintana, H., Zwißler, B., & Eltzschig, H. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401957 · Cited by 89
Fu, W., McCormick, T., Qi, X., Luo, L., Zhou, L., Li, X., Wang, B.-C., Gibbons, H. E., Abdul‐Karim, F. W., & Gorodeski, G. I. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-114 · Cited by 89
Peng, H., Zou, L., Xie, J., Wu, H., Wu, B., Zhu, G., Lv, Q., Zhang, X., Liu, S., Li, G., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9632-1 · Cited by 89
An Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease
Jenner, P. G. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00003-9 · Cited by 89
Neuron–microglia interaction by purinergic signaling in neuropathic pain following neurodegeneration
Tsuda, M., & Inoue, K. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.042 · Cited by 88
Beneficial and detrimental role of adenosine signaling in diseases and therapy
Liu, H., & Xia, Y. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00350.2015 · Cited by 88
Purinergic signalling in the reproductive system in health and disease
Burnstock, G. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9399-7 · Cited by 86
Self-citationPhysiopathological Roles of P2X Receptors in the Central Nervous System
Burnstock, G. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706130415 · Cited by 86
Self-citationAntonioli, L., Colucci, R., Pellegrini, C., Giustarini, G., Tuccori, M., Blandizzi, C., & Fornai, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.002 · Cited by 86
Bar‐Yehuda, S., Silverman, M. H., Kerns, W., Ochaion, A., Cohen, S., & Fishman, P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1601 · Cited by 86
Purinergic signaling in retinal degeneration and regeneration
Reichenbach, A., & Bringmann, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.005 · Cited by 85
Takai, E., Tsukimoto, M., Harada, H., & Kojima, S. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9411-x · Cited by 85
Zhao, H., Zhang, X., Dai, Z., Feng, Y., Li, Q., Zhang, J. H., Liu, X., Chen, Y., & Feng, H. (2016) · Scientific Reports · doi:10.1038/srep23286 · Cited by 84
Fumagalli, M., Lecca, D., & Abbracchio, M. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.005 · Cited by 84
Azimi, I., Beilby, H., Davis, F. M., Marcial, D. L., Kenny, P. A., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.09.006 · Cited by 84
Short- and long-term (trophic) purinergic signalling
Burnstock, G. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0422 · Cited by 84
Self-citationChiang, D. J., Roychowdhury, S., Bush, K., McMullen, M. R., Pisano, S. G., Niese, K. A., Olman, M. A., Pritchard, M. T., & Nagy, L. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069114 · Cited by 83
P2Y2 receptor agonists for the treatment of dry eye disease: a review
Skalicky, S. E., Lau, O. C. F., & Samarawickrama, C. (2014) · Clinical ophthalmology · doi:10.2147/opth.s39699 · Cited by 83
Adenosine, adenosine receptors and glaucoma: An updated overview
Zhong, Y., Yang, Z., Huang, W.-C., & Luo, X. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.005 · Cited by 83
Adenosine and protection from acute kidney injury
Yap, S. C., & Lee, H. T. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834d2ec9 · Cited by 82
Li, Y., He, Y., Chen, M., Pu, Z., Chen, L., Li, P., Li, B., Li, H., Huang, Z., Li, Z., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.227 · Cited by 82
Mechanism of microglia neuroprotection: Involvement of P2X 7,TNF α, and valproic acid
Masuch, A., Shieh, C., van Rooijen, N., van Calker, D., & Biber, K. (2016) · Glia · doi:10.1002/glia.22904 · Cited by 81 · cited 1×
“Neuroprotection mediated by microglia is associated with P2X7R activation and release of tumour necrosis factor-α (Masuch et al., 2016).”
BackgroundThe role of p2x7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases
Coutinho-Silva, R., Morandini, A., & Savio, L. B. (2014) · Biomedical Journal · doi:10.4103/2319-4170.127803 · Cited by 81
P2X Receptors and Inflammation
Virgilio, F. D. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141210155311 · Cited by 81
Ursu, D., Ebert, P. J., Langron, E., Ruble, C., Munsie, L. M., Zou, W., Fijal, B. A., Qian, Y., McNearney, T. A., Mogg, A. J., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-37 · Cited by 81
The evolution of P2X7 antagonists with a focus on CNS indications
Rech, J. C., Bhattacharya, A., Letavic, M. A., & Savall, B. M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.048 · Cited by 81
Purinergic contribution to amyotrophic lateral sclerosis
Volonté, C., Apolloni, S., Parisi, C., & Amadio, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.026 · Cited by 80
Squadrito, F., Bitto, A., Altavilla, D., Arcoraci, V., Caridi, G. D., Feo, M. E. D., Corrao, S., Pallio, G., Sterrantino, C., Minutoli, L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3569 · Cited by 80
Purine nucleosides in neuroregeneration and neuroprotection
Ribeiro, F. F., Xapelli, S., Miranda‐Lourenço, C., Tanqueiro, S. R., Fonseca‐Gomes, J., Diógenes, M. J., Ribeiro, J. A., & Sebastião, A. M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.006 · Cited by 80
Bulluck, H., Sirker, A., Loke, Y. K., David Garcia-dorado, A., & Hausenloy, D. J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.005 · Cited by 80
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
Pedata, F., Pugliese, A. M., Coppi, E., Dettori, I., Maraula, G., Cellai, L., & Melani, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/805198 · Cited by 80
Liu, R., Wang, H., Xu, B., Chen, W., Turlova, E., Dong, N., Sun, C. L. F., Lu, Y., Fu, H., Shi, R., et al. (2016) · Diabetes · doi:10.2337/db15-1737 · Cited by 80
Swiatkowski, P., Murugan, M., Eyo, U. B., Wāng, Y., Rangaraju, S., Oh, S. B., & Wu, L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.008 · Cited by 79
Xu, P., Xu, Y., Hu, B., Wang, J., Pan, R., Murugan, M., Wu, L., & Tang, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.020 · Cited by 78
Matsumoto, T., Goulopoulou, S., Taguchi, K., Tostes, R. C., & Kobayashi, T. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13205 · Cited by 78
P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats
Ji, X., Naito, Y., Hirokawa, G., Weng, H., Hiura, Y., Takahashi, R., & Iwai, N. (2011) · Hypertension Research · doi:10.1038/hr.2011.153 · Cited by 78
Blockade of P2X7 Receptors or Pannexin-1 Channels Similarly Attenuates Postischemic Damage
Cisneros-Mejorado, A., Gottlieb, M., Cavaliere, F., Magnus, T. U., Koch‐Nolte, F., Scemes, E., Pérez‐Samartín, A., & Matute, C. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.262 · Cited by 78
Purinergic Signaling and the Immune Response in Sepsis: A Review
Ledderose, C., Bao, Y., Kondo, Y., Fakhari, M., Slubowski, C. J., Zhang, J., & JUNGER, W. G. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.04.002 · Cited by 78
Figliuolo, V. R., Savio, L. E. B., Safya, H., Nanini, H. F., Bernardazzi, C., Abalo, A., de Souza, H. S. P., Kanellopoulos, J., Bobé, P., Coutinho, C. M. L. M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.004 · Cited by 78
Bravo, D., Maturana, C. J., Pélissier, T., Hernández, A., & Constandil, L. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.016 · Cited by 77
Merighi, S., Simioni, C., Gessi, S., Varani, K., Mirandola, P., Tabrizi, M. A., Baraldi, P. G., & Borea, P. A. (2009) · Neoplasia · doi:10.1593/neo.09768 · Cited by 77
Sauer, A. V., Mrak, E., Hernández, R. J., Zacchi, E., Cavani, F., Casiraghi, M., Grunebaum, E., Roifman, C. M., Cervi, M. C., Ambrosi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209221 · Cited by 77
Dai, S.-S., & Zhou, Y. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.020 · Cited by 77
Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice
Beaucage, K. L., Xiao, A., Pollmann, S. I., Grol, M. W., Beach, R. J., Holdsworth, D. W., Sims, S. M., Darling, M., & Dixon, S. J. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9388-x · Cited by 77
P2X7 receptor inhibition protects against ischemic acute kidney injury in mice
Yan, Y., Bai, J., Zhou, X., Tang, J., Jiang, C., Tolbert, E. M., Bayliss, G. P., Gong, R., Zhao, T. C., & Zhuang, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00245.2014 · Cited by 77
Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis
Shaikh, G., & Cronstein, B. N. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9498-3 · Cited by 76
P2X7 receptors: role in bone cell formation and function
Agrawal, A., & Gartland, A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0226 · Cited by 76
Blood cells: an historical account of the roles of purinergic signalling
Burnstock, G. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9462-7 · Cited by 75
Self-citationVázquez‐Cuevas, F. G., Martínez-Ramírez, A. S., Robles-Martínez, L., Garay, E., García-Carrancá, A. M., Pérez‐Montiel, D., Castañeda-García, C., & Arellano, R. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24867 · Cited by 75
Hansen, R. R., Nasser, A., Falk, S., Baldvinsson, S. B., Ohlsson, P. H., Bahl, J. M. C., Jarvis, M. F., Ding, M. L., & Heegaard, A. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.008 · Cited by 75
Purinergic signalling in endocrine organs
Burnstock, G. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9396-x · Cited by 75
Self-citationGu, B. J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T. J., Lechner‐Scott, J., Scott, R. J., Lea, R. A., Taylor, B. V., Stankovich, J. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv278 · Cited by 75
Inhibition of the P2X7 Receptor Reduces Cystogenesis in PKD
Chang, M., Lu, J., Tian, Y., Chen, Y., Hung, C., Huang, Y.-H., Chen, Y., Wu, M.-S., Yang, C., & Cheng, Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070728 · Cited by 75
Mazzon, E., Esposito, E., Impellizzeri, D., Paola, R. D., Melani, A., Bramanti, P., Pedata, F., & Cuzzocrea, S. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110111 · Cited by 75
Purinergic signaling in Parkinson's disease. Relevance for treatment
Navarro, G., Borroto‐Escuela, D. O., Fuxé, K., & Franco, R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.024 · Cited by 74
Du, X., Ou, X., Song, T., Zhang, W., Cong, F., Zhang, S., & Xiong, Y. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215584939 · Cited by 74
He, W., Mazumder, A., Wilder, T., & Cronstein, B. N. (2013) · The FASEB Journal · doi:10.1096/fj.13-231233 · Cited by 74
Lapa, F. D. R., da Silva, M. D., Cabrini, D. A., & Santos, A. R. S. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9299-2 · Cited by 74
Increased uric acid levels in bipolar disorder subjects during different phases of illness
Albert, U., Cori, D. D., Aguglia, A., Barbaro, F., Bogetto, F., & Maina, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.005 · Cited by 74
Furlong, T. M., Supit, A. S. A., Corbit, L. H., Killcross, S., & Balleine, B. W. (2015) · Addiction Biology · doi:10.1111/adb.12316 · Cited by 73
Sun, H., Xu, B., Chen, W., Xiao, A.-J., Turlova, E., Alibraham, A., Barszczyk, A., Bae, C. Y.-J., Quan, Y., Liu, B., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.10.003 · Cited by 73
Elevated Placental Adenosine Signaling Contributes to the Pathogenesis of Preeclampsia
Iriyama, T., Sun, K., Parchim, N. F., Li, J. L., Zhao, C., Song, A., Hart, L. A., Blackwell, S. C., Sibai, B. M., Chan, L.-N. L., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.013740 · Cited by 73
Human melanomas express functional P2X7 receptors
White, N., Butler, P. E. M., & Burnstock, G. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1149-x · Cited by 73
Self-citationXiao, F., Waldrop, S. L., Khimji, A.-K., & Kilic, G. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00175.2012 · Cited by 73
Wirsdörfer, F., de Leve, S., Cappuccini, F., Eldh, T., Meyer, A. V., Gau, E., Thompson, L. F., Chen, N., Karmouty‐Quintana, H., Fischer, U., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2310 · Cited by 73
The therapeutic agents that target ATP-sensitive potassium channels
Rubaiy, H. N. (2016) · Acta Pharmaceutica · doi:10.1515/acph-2016-0006 · Cited by 73
Varani, K., Vincenzi, F., Tosi, A., Targa, M., Masieri, F. F., Ongaro, A., Mattei, M. D., Massari, L., & Pa, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00667.x · Cited by 72
Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Lindberg, D. M., Shan, D., Ayers-Ringler, J. R., Oliveros, A., Benitez, J. C. A., Prieto, M. L., McCullumsmith, R. E., & Choi, D. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330163724 · Cited by 72
Gómez‐Villafuertes, R., García-Huerta, P., Díaz‐Hernandéz, J. I., & Miras‐Portugal, M. T. (2015) · Scientific Reports · doi:10.1038/srep18417 · Cited by 72
P2 receptors, microglial cytokines and chemokines, and neuropathic pain
Tsuda, M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23816 · Cited by 72
Tian, T., Zhou, Y., Feng, X., Ye, S., Wang, H., Wu, W., Tan, W., Yu, C., Hu, J., Zheng, R., et al. (2016) · Scientific Reports · doi:10.1038/srep30824 · Cited by 72
P2X7 Receptor Modulates Inflammatory and Functional Pulmonary Changes Induced by Silica
Monção-Ribeiro, L. C., Faffe, D. S., Santana, P. T., Vieira, F. S., da Graça, C. L. A. L., Marques-da-Silva, C., Machado, M. N., Caruso-Neves, C., Zin, W. A., Borojevic, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110185 · Cited by 71
Purinergic receptor‐mediated effects of ATP in high‐grade bladder cancer
Shabbir, M., Ryten, M., Thompson, C. S., Mikhailidis, D. P., & Burnstock, G. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07286.x · Cited by 71
Self-citationAghaei, M., Karami‐Tehrani, F., Panjehpour, M., Salami, S., & Fallahian, F. (2011) · The Prostate · doi:10.1002/pros.21438 · Cited by 71
Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins
Diezmos, E. F., Bertrand, P. P., & Liu, L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00311 · Cited by 71
Daniele, S., Zappelli, E., Natali, L., Martini, C., & Trincavelli, M. L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.487 · Cited by 69
Pathophysiology of Overactive Bladder
Meng, E., Lin, W., Lee, W., & Chuang, Y. (2012) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/j.1757-5672.2011.00122.x · Cited by 69
Avendaño, B. C., Montero, T. D., Chávez, C. E., Rommy von Bernhardi, M., & Orellana, J. A. (2015) · Glia · doi:10.1002/glia.22877 · Cited by 69
Hu, H., Yang, B., Li, Y., Zhang, S., & Li, Z. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2770 · Cited by 69
Sinadinos, A., Young, C., Al-khalidi, R. A. A., Teti, A. M., Kaliński, P., Mohamad, S., Floriot, L., Henry, T., Tozzi, G., Jiang, T., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001888 · Cited by 68
Chaves, M. M., Marques-da-Silva, C., Monteiro, A. P. T., Canetti, C. D. A., & Coutinho‐Silva, R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301058 · Cited by 68
Lu, W., Hu, H.-L., Sévigny, J., Gabelt, B. T., Kaufman, P. L., Johnson, E. C., Morrison, J. C., Zode, G. S., Sheffield, V. C., Zhang, X., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15891 · Cited by 68
Mishra, A., Guo, Y., Zhang, L., More, S., Weng, T., Chintagari, N. R., Huang, C., Liang, Y., Pushparaj, S., Gou, D., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501041 · Cited by 68
Burnstock, G. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56921-0_6 · Cited by 67
Self-citationNeuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Rao, K. V. R., & Kielian, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12237 · Cited by 67
Singh, S., Roy, K. K., Khan, S. R., Kashyap, V. K., Sharma, A., Jaiswal, S., Sharma, S., Krishnan, M. Y., Chaturvedi, V., Lal, J., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.060 · Cited by 67
Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells.
Burnstock, G. (2008) · PubMed · Cited by 67
Self-citationPereira, V. S., Casarotto, P. C., Hiroaki-Sato, V. A., Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.01.008 · Cited by 66
Jp, M., Silva, R. B. M., Coutinho‐Silva, R., Takiya, C. M., Battastini, A., Morrone, F. B., & Campos, M. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01535.x · Cited by 66
Antonioli, L., Giron, M. C., Colucci, R., Pellegrini, C., Sacco, D., Caputi, V., Orso, G., Tuccori, M., Scarpignato, C., Blandizzi, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116253 · Cited by 66
Fausther, M., Sheung, N., Saiman, Y., Bansal, M. B., & Dranoff, J. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00015.2012 · Cited by 66
Costello, J. C., Rosenthal, A. K., Kurup, I. V., Masuda, I., Medhora, M. M., & Ryan, L. M. (2010) · Connective Tissue Research · doi:10.3109/03008207.2010.491928 · Cited by 66
Xie, Y., Williams, C. D., McGill, M. R., Lebofsky, M., Ramachandran, A., & Jaeschke, H. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs283 · Cited by 65
New Drugs and Treatment Targets in Psoriasis
Kofoed, K. F., Skov, L., & Zachariae, C. O. C. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-1931 · Cited by 65
Kim, H., Walsh, M. C., Takegahara, N., Middleton, S. A., Shin, H., Kim, J., & Choi, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00139-2 · Cited by 65
ATP and P2X Purinoceptors in Urinary Tract Disorders
Ford, A. P. D. W., & Cockayne, D. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-16499-6_22 · Cited by 64
Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts
Nakamachi, Y., Koshiba, M., Nakazawa, T., Hatachi, S., Saura, R., Kurosaka, M., Kusaka, H., & Kumagai, S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10956 · Cited by 64
Regulation of Foam Cells by Adenosine
Reiss, A. B., & Cronstein, B. N. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226878 · Cited by 64
Coughlan, K. S., Mitchem, M. R., Hogg, M. C., & Prehn, J. H. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.022 · Cited by 64
P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction
Savio, L. E. B., Andrade, M. G. J., de Andrade Mello, P., Santana, P. T., Moreira-Souza, A. C. A., Kolling, J., Longoni, A., Feldbrügge, L., Wu, Y., Wyse, A. T. S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0168-9 · Cited by 64
Darville, T. L., Welter-Stahl, L., da Cruz, C. M., Sater, A. A. A., Andrews, C. W., & Ojcius, D. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3707 · Cited by 63
Sebastián‐Serrano, Á., Engel, T., de Diego-García, L., Olivos-Oré, L. A., Arribas-Blázquez, M., Martínez-Frailes, C., Pérez-Díaz, C., Millán, J. L., Artalejo, A. R., Miras‐Portugal, M. T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw248 · Cited by 63
Adenosine Signaling in Striatal Circuits and Alcohol Use Disorders
Nam, H. W., Bruner, R. C., & Choi, D. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0192-9 · Cited by 62
Ryten, M., Yang, S. Y., Dunn, P. M., Goldspink, G., & Burnstock, G. (2004) · The FASEB Journal · doi:10.1096/fj.03-1175fje · Cited by 62
Self-citationDeiteren, A., van der Linden, L., de Wit, A. E., Ceuleers, H., Buckinx, R., Timmermans, J., Moreels, T. G., Pelckmans, P. A., Man, J. G. D., & Winter, B. Y. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123810 · Cited by 62
Straub, R. H., Rauch, L., Faßold, A., Lowin, T., & Pongratz, G. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24030 · Cited by 62
Şeref-Ferlengez, Z., Maung, S., Schaffler, M. B., Spray, D. C., Suadicani, S. O., & Thi, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155107 · Cited by 62
P2X7 receptor‐induced death of motor neurons by a peroxynitrite/ FAS ‐dependent pathway
Gandelman, M., Levy, M., Cassina, P., Barbeito, L., & Beckman, J. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12286 · Cited by 61
Taylor, J. M., & Han, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015784 · Cited by 61
Franklin, K. M., Asatryan, L., Jakowec, M. W., Trudell, J. R., Bell, R. L., & Davies, D. L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00176 · Cited by 61
Schneider, G., Glaser, T., Lameu, C., Abdelbaset‐Ismail, A., Sellers, Z. P., Moniuszko, M., Ulrich, H., & Ratajczak, M. Z. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0469-z · Cited by 61
ATP stimulates pannexin 1 internalization to endosomal compartments
Boyce, A. K. J., Kim, M. S., Wicki‐Stordeur, L. E., & Swayne, L. A. (2015) · Biochemical Journal · doi:10.1042/bj20141551 · Cited by 61
Purinergic signaling in epilepsy
Rassendren, F., & Audinat, É. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23770 · Cited by 61
Torres, Á., Vargas, Y., Uribe, D., Jaramillo, C., Gleisner, M. A., Salazar‐Onfray, F., López, M. N., Melo, R., Oyarzun, C. E., Martín, R. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12033 · Cited by 61
Braganhol, E., Kukulski, F., Lévesque, S. A., Fausther, M., Lavoie, É. G., Zanotto‐Filho, A., Bergamin, L. S., Pelletier, J., Bahrami, F., Yebdri, F. B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.014 · Cited by 60
Sympathetic overactivity and arterial hypertension in renal failure
Orth, S. R., Amann, K., Strojek, K., & Ritz, E. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.67 · Cited by 60
Potential for Developing Purinergic Drugs for Gastrointestinal Diseases
Ochoa‐Cortés, F., Liñán-Rico, A., Jacobson, K. A., & Christofi, F. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000047 · Cited by 60
Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action
Stamp, L. K., Hazlett, J., Roberts, R. L., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3871 · Cited by 60
Nociceptive transmission and modulation via P2X receptors in central pain syndrome
Kuan, Y., & Shyu, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0240-4 · Cited by 60
Portales‐Cervantes, L., Niño-Moreno, P., Doníz-Padilla, L., Baranda-Candido, L., García-Hernández, M. H., Salgado‐Bustamante, M., González‐Amaro, R., & Portales‐Pérez, D. P. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.05.008 · Cited by 59
Ru, Q., Tian, X., Wu, Y., Wu, R., Pi, M., & Li, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2875 · Cited by 59
Rockenbach, L., Bavaresco, L., Farias, P. F., Cappellari, A. R., Barrios, C. H., Morrone, F. B., & Battastini, A. M. O. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.10.009 · Cited by 59
Choukèr, A., Thiel, M., Lukashev, D. E., Ward, J. M., Kaufmann, I., Apasov, S. G., Sitkovsky, M. V., & Ohta, A. (2008) · Molecular Medicine · doi:10.2119/2007-00075.chouker · Cited by 59
Identification of A3adenosine receptor agonists as novel non‐narcotic analgesics
Janes, K., Symons-Liguori, A. M., Jacobson, K. A., & Salvemini, D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13446 · Cited by 59
Olivier, E., Dutot, M., Regazzetti, A., Léguillier, T., Dargère, D., Auzeil, N., Laprévôte, O., & Rat, P. (2016) · Biochimie · doi:10.1016/j.biochi.2016.04.014 · Cited by 59
da Silva, M. V., Marosti, A. R., Mendes, C. E., Palombit, K., & Castelucci, P. (2014) · Histochemistry and Cell Biology · doi:10.1007/s00418-014-1270-6 · Cited by 58
Targeting P2X7 receptor for the treatment of central post-stroke pain in a rodent model
Kuan, Y., Shih, H.-C., Tang, S., Jeng, J., & Shyu, B. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.028 · Cited by 58
Ikeda, N., Murata, S., Maruyama, T., Tamura, T., Nozaki, R., Kawasaki, T., Fukunaga, K., Oda, T., Sasaki, R., Homma, M., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00893.x · Cited by 58
Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure
Greene, S. J., Sabbah, H. N., Butler, J., Voors, A. A., Albrecht-Küpper, B. E., Düngen, H., Dinh, W., & Gheorghiade, M. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9522-7 · Cited by 58
Olatunji, O. J., Feng, Y., Olatunji, O. O., Tang, J., Ouyang, Z., Su, Z., Wang, D., & Yu, X. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.02.009 · Cited by 58
Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis
Sadovnick, A. D., Gu, B. J., Traboulsee, A. L., Bernales, C. Q., Encarnacion, M. J., Yee, I. M. L., Criscuoli, M. G., Huang, X., Ou, A., Milligan, C. J., et al. (2017) · Human Mutation · doi:10.1002/humu.23218 · Cited by 58
Graubardt, N., Fahrner, R., Trochsler, M., Keogh, A., Breu, K., Furer, C., Stroka, D., Robson, S. C., Slack, E. M. C., Candinas, D., et al. (2012) · Hepatology · doi:10.1002/hep.26008 · Cited by 57
Ng, S. K., Higashimori, H., Tolman, M., & Yang, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.004 · Cited by 57
Activation of ureter nociceptors by exogenous and endogenous ATP in guinea pig
Rong, W., & Burnstock, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.003 · Cited by 57
Self-citationCaseley, E. A., Muench, S. P., Roger, S., Mao, H., Baldwin, S. A., & Jiang, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813344 · Cited by 57
P2Y2R activation by nucleotides promotes skin wound‐healing process
Jin, H., Seo, J., Eun, S. Y., Joo, Y. N., Park, S. W., Lee, J. H., Chang, K. C., & Kim, H. J. (2014) · Experimental Dermatology · doi:10.1111/exd.12440 · Cited by 57
Song, H., Han, Y., Pan, C., Deng, X., Dai, W., Hu, L., Jiang, C., Yang, Y., Cheng, Z., Li, F. Y., et al. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000856 · Cited by 57
Hurtado‐Alvarado, G., Domı́nguez-Salazar, E., Velázquez‐Moctezuma, J., & Gómez‐González, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167236 · Cited by 57
Komai, A. M., Brännmark, C., Musovic, S., & Olofsson, C. S. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.280388 · Cited by 56
Renal P2 receptors and hypertension
Menzies, R. I., Unwin, R. J., & Bailey, M. A. (2014) · Acta Physiologica · doi:10.1111/apha.12412 · Cited by 56
Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity
Amaral, S. S., de Oliveira, A. G., Marques, P. E., Quintão, J. L. D., Pires, D. A., Resende, R. R., de Sousa, B. R., Melgaço, J. G., Pinto, M. A., Russo, R. C., et al. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-10 · Cited by 56
Agteresch, H. J., Burgers, S. A., van der Gaast, A., Wilson, J. H. P., & Dagnelie, P. C. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200309000-00009 · Cited by 55
von Versen‐Höynck, F., Rajakumar, A., Bainbridge, S. A., Gallaher, M. J., Roberts, J. M., & Powers, R. W. (2009) · Placenta · doi:10.1016/j.placenta.2009.02.004 · Cited by 55
Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7
Hattori, F., Ohshima, Y., Seki, S., Tsukimoto, M., Sato, M., Takenouchi, T., Suzuki, A., Takai, E., Kitani, H., Harada, H., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.001 · Cited by 55
Ma, M., Ren, Q., Zhang, J.-C., & Hashimoto, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.31 · Cited by 55
Tak, E., Ridyard, D. G., Kim, J., Zimmerman, M., Werner, T., Wang, X. X., Shabeka, U., Seo, S.-W., Christians, U., Klawitter, J., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101014 · Cited by 55
Tu, G., Zou, L., Liu, S., Wu, B., Lv, Q., Wang, S., Xue, Y., Zhang, C., Yi, Z., Zhang, X., et al. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9518-3 · Cited by 55
Yegutkin, G. G., Guerrero-Toro, C., Kılınç, E., Koroleva, K., Ishchenko, Y., Abushik, P. A., Giniatullina, R., Fayuk, D. A., & Giniatullin, R. A. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9521-8 · Cited by 55
Yan, S., Wu, L., Wu, L., Zhong, C., Zhong, C., Yu, Q., Wang, Y., Lue, L., Douglas, J. T., Douglas, J. T., et al. (2016) · Diabetes · doi:10.2337/db16-0556 · Cited by 55
Yoneyama, Y., Sawa, R., Suzuki, S., Shin, S., Power, G. G., & Araki, T. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70406-4 · Cited by 54
Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing
Gendaszewska‐Darmach, E., & Kucharska, M. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9233-z · Cited by 54
Gazzerro, E., Baldassari, S., Assereto, S., Fruscione, F., Pistorio, A., Panicucci, C., Volpi, S., Perruzza, L., Fiorillo, C., Minetti, C., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.010 · Cited by 53
Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy
Holst, S. C., Valomon, A., & Landolt, H. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103801 · Cited by 53
Desensitization properties of P2X3 receptors shaping pain signaling
Giniatullin, R. A., & Nistri, A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00245 · Cited by 53
Wei, Q., Costanzi, S., Liu, Q., Gao, Z., & Jacobson, K. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.013 · Cited by 53
Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis
Husted, L. B., Harsløf, T., Stenkjær, L. L., Carstens, M., Jørgensen, N. R., & Langdahl, B. L. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2035-5 · Cited by 53
Vincenzi, F., J, M. P. J., Targa, M., Corciulo, C., Giacuzzo, S., Merighi, S., Gessi, S., Govoni, M., Borea, P. A., & Varani, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054195 · Cited by 53
Santana, P. T., Benjamim, C. F., Martinez, C. G., Kurtenbach, E., Takiya, C. M., & Coutinho‐Silva, R. (2015) · Journal of Innate Immunity · doi:10.1159/000371388 · Cited by 53
The role of the adenosinergic system in lung fibrosis
Latta, V. D., Cabiati, M., Rocchiccioli, S., Ry, S. D., & Morales, M. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.08.004 · Cited by 53
An in vivo model of melanoma: treatment with ATP
White, N. F., Knight, G. E., Butler, P. E. M., et al. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9156-0 · Cited by 53
Sáez-Orellana, F., Godoy, P. A., Bastidas, C. Y., Silva-Grecchi, T., Guzmán, L., Aguayo, L. G., & Fuentealba, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.005 · Cited by 53
Deplano, S., Cook, H. T., Russell, R. F., Franchi, L., Schneiter, S., Bhangal, G., Unwin, R. J., Pusey, C. D., Tam, F. W. K., & Behmoaras, J. V. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0612284 · Cited by 53
The P2X4 receptor is required for neuroprotection via ischemic preconditioning
Ozaki, T., Muramatsu, R., Sasai, M., Yamamoto, M., Kubota, Y., Fujinaka, T., Yoshimine, T., & Yamashita, T. (2016) · Scientific Reports · doi:10.1038/srep25893 · Cited by 53
de Oliveira, C. C., Caria, C. R. E. P., Gotardo, É. M. F., Ribeiro, M. L., & Gambero, A. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.017 · Cited by 53
P2X7 receptor as predictor gene for glioma radiosensitivity and median survival
Gehring, M. P., Kipper, F. C., Nicoletti, N. F., Sperotto, N. D. D. M., Zanin, R. F., Tamajusuku, A. S. K., Flores, D. G., Meurer, L., Roesler, R., Filho, A. B., et al. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.09.001 · Cited by 52
Sun, L., Gao, J., Zhao, M., Cui, J., Li, Y., Yang, X., Jing, X., & Wu, Z. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.049 · Cited by 52
The role of adenosine receptors in rheumatoid arthritis
Varani, K., J, M. P. J., Govoni, M., Vincenzi, F., Trotta, F., & Borea, P. A. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.019 · Cited by 52
Jalkanen, J. M., Yegutkin, G. G., Hollmén, M., Aalto, K., Kiviniemi, T., Salomaa, V. V., Jalkanen, S., & Hakovirta, H. H. (2015) · Circulation Research · doi:10.1161/circresaha.116.305715 · Cited by 52
Purinergic receptors: new targets for the treatment of gout and fibrosis
Gicquel, T., Daré, B. L., Boichot, E., & Lagente, V. (2016) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12256 · Cited by 52
P2Y receptors in Alzheimer's disease
Erb, L., Chen, C., Ajit, D., & Weisman, G. A. (2014) · Biology of the Cell · doi:10.1111/boc.201400043 · Cited by 51
Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety
Chiu, G. S., Darmody, P. T., Walsh, J. P., Moon, M. L., Kwakwa, K. A., Bray, J. K., McCusker, R. H., & Freund, G. G. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.018 · Cited by 51
Neural regulation of inflammation in the airways and lungs
McGovern, A. E., & Mazzone, S. B. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.12.008 · Cited by 51
Baudelet, D., Lipka, E., Millet, R., & Ghinet, A. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141212120926 · Cited by 51
Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy
Morrone, F. B., Gehring, M. P., & Nicoletti, N. F. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103770 · Cited by 51
Bergamin, L. S., Braganhol, E., Figueiró, F., Casali, É. A., Zanin, R. F., Sévigny, J., & Battastini, A. M. O. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25018 · Cited by 50
Effects of Aerosolized Adenosine 5′-Triphosphate in Smokers and Patients With COPD
Başoğlu, Ö. K., Barnes, P. J., Kharitonov, S. A., et al. (2015) · CHEST Journal · doi:10.1378/chest.14-2285 · Cited by 50
Luo, F., Le, N., Mills, T., Chen, N., Karmouty‐Quintana, H., Molina, J. G., Davies, J., Philip, K., Volcik, K. A., Liu, H., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-274845 · Cited by 50
P2X1-regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration
Kudira, R., Malinka, T., Kohler, A., Dosch, M., de Agüero, M. G., Melin, N., Haegele, S., Starlinger, P., Maharjan, N., Saxena, S., et al. (2016) · Hepatology · doi:10.1002/hep.28492 · Cited by 50
Role of the purinergic signaling in epilepsy
Cieślak, M., Wojtczak, A., & Komoszyński, M. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.09.018 · Cited by 50
Wu, W., He, Y., Feng, X., Ye, S., Wang, H., Tan, W., Yu, C., Hu, J., Zheng, R., & Zhou, Y. J. (2016) · Oncotarget · doi:10.18632/oncotarget.13525 · Cited by 50
Adenosine contribution to normal renal physiology and chronic kidney disease
Oyarzun, C. E., Garrido, W., Alarcón, S., Yáñez, A. J., Sobrevía, L., Quezada, C., & Martín, R. S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.004 · Cited by 50
Steculorum, S. M., Timper, K., Engström, L., Evers, N., Paeger, L., Bremser, S., Kloppenburg, P., & Brüning, J. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.047 · Cited by 50
Purinergic receptor‐mediated effects of adenosine 5′‐triphosphate in urological malignant diseases
Shabbir, M., & Burnstock, G. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02207.x · Cited by 49
Self-citationAdenosine Signaling, Priapism and Novel Therapies
Dai, Y., Zhang, Y., Phatarpekar, P. V., Mi, T., Zhang, H., Blackburn, M. R., & Xia, Y. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01187.x · Cited by 49
Cunha, M. P., Pazini, F. L., Rosa, J. M., Ramos-Hryb, A. B., Oliveira‐Giacomelli, Á., Kaster, M. P., & Rodrigues, A. L. S. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9446-7 · Cited by 49
Role of adenosine in the antiepileptic effects of deep brain stimulation
Miranda, M. F., Hamani, C., de Almeida, A. ́.-C. G., Amorim, B. O., de Macedo, C. E. A., Fernandes, M. J. D. S., Nobrega, J. N., Aarão, M. C., Madureira, A. P., Rodrigues, A. ́. M., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00312 · Cited by 49
The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro
Agrawal, A., Buckley, K. M., Bowers, K. C., Furber, M., Gallagher, J. A., & Gartland, A. (2010) · Purinergic Signalling · doi:10.1007/s11302-010-9181-z · Cited by 49
Imarisio, C., Alchera, E., Sutti, S., Valente, G., Boccafoschi, F., Albano, E., & Carini, R. (2012) · Clinical Science · doi:10.1042/cs20110504 · Cited by 49
Gölöncsér, F., & Sperlágh, B. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-24 · Cited by 49
Kitta, T., Chancellor, M. B., de Groat, W. C., Kuno, S., Nonomura, K., & Yoshimura, N. (2012) · The Journal of Urology · doi:10.1016/j.juro.2011.12.062 · Cited by 49
Adenosine regulation of the immune response initiated by ischemia reperfusion injury
Boros, D., Thompson, J., & Larson, D. (2015) · Perfusion · doi:10.1177/0267659115586579 · Cited by 49
Khoja, S., Shah, V. D., Garcia, D., Asatryan, L., Jakowec, M. W., & Davies, D. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13734 · Cited by 49
Bhave, S. M., Gade, A. R., Kang, M., Hauser, K. F., Dewey, W. L., & Akbarali, H. I. (2017) · The FASEB Journal · doi:10.1096/fj.201601068r · Cited by 49
Crossland, R. F., Durgan, D. J., Lloyd, E. E., Phillips, S. C., Reddy, A. K., Marrelli, S. P., & Bryan, R. M. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00244.2013 · Cited by 48
Bartoli, F., Crocamo, C., Dakanalis, A., Brosio, E., Miotto, A., Capuzzi, E., Clerici, M., & Carrà, G. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.09.011 · Cited by 48
Cited by
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437
Danger signals in stroke and their role on microglia activation after ischemia
Gülke, E., Gelderblom, M., & Magnus, T. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418774254 · Cited by 321
Mechanisms of ATP Release by Inflammatory Cells
Dosch, M., Gerber, J., Jebbawi, F., & Beldi, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041222 · Cited by 283
Metadata
- Authors
- Burnstock, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-25
- Volume
- 8
- Pages
- 661-661
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2759752974
- Cited by
- 398
- References
- 724
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.